Related Experiment Video
Updated: Aug 11, 2026

18:48
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
CD4+CD25+ regulatory T lymphocytes in bone marrow transplantation
Olivier Joffre1, Joost P M van Meerwijk
1Tolerance and Autoimmunity Section, INSERM U563, Université Paul Sabatier, IFR 30, Purpan Hospital, BP 3028, 31024 Toulouse Cedex 3, France.
Seminars in Immunology
|February 7, 2006
Summary
Inducing immunological tolerance with regulatory T cells, specifically CD4(+)CD25(+) T cells, offers a promising strategy to prevent graft-versus-host disease and allograft rejection in transplantation.
Area of Science:
- Transplantation immunology
- Immunological tolerance
- Regulatory T cell biology
Background:
- Graft-versus-host disease (GvHD) and allograft rejection are major challenges in transplantation medicine.
- Preventing immune responses to alloantigens is crucial for successful transplantation.
- Natural self-tolerance mechanisms, particularly dominant tolerance mediated by regulatory T lymphocytes, offer a potential therapeutic avenue.
Purpose of the Study:
- To review and discuss recent advances in inducing transplantation tolerance.
- To explore the application of regulatory T cells, specifically CD4(+)CD25(+) T cells, for preventing GvHD and allograft rejection.
Main Methods:
- Review of current literature on regulatory T cell function and transplantation tolerance.
- Discussion of CD4(+)CD25(+) T cell populations as a tool for inducing tolerance.
Main Results:
- CD4(+)CD25(+) T cells are a well-characterized regulatory T lymphocyte population.
- These cells play a significant role in dominant self-tolerance mechanisms.
- Their application in transplantation holds promise for preventing GvHD and rejection.
Conclusions:
- Harnessing regulatory T cell-mediated tolerance is an attractive strategy for transplantation.
- CD4(+)CD25(+) T cells represent a key population for inducing tolerance to alloantigens.
- Further research into regulatory T cell-based therapies could significantly improve transplant outcomes.
Related Concept Videos
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...

